All News
Frank Buttgereit discusses potential reason for ceiling effect in RA and questions why we don’t use more combination therapy in RA (including low dose of of GC), using the example of Hypertension guidelines
Is long term low dose GC in RA really a desirable option?
@RheumNow… https://t.co/Nc7lldN7Nd https://t.co/63K96uuhKG
Links:
Aurelie Najm AurelieRheumo ( View Tweet)
Tips to help in self-management. Procrastination is a huge barrier to self-management. Delegate and prioritise #EULAR2024 Andrea Marques @RheumNow https://t.co/SbQgOMwqL0
Links:
Dr. Antoni Chan synovialjoints ( View Tweet)
Steroids are often started before pts see a rheumatologist
This associates with long-term low-dose steroid use
Need better collaboration between referrers and rheum to reduce this avoidable steroid burden
POS0137 @RheumNow #EULAR2024
Mrinalini Dey DrMiniDey ( View Tweet)
#EULAR2024 POS0436 Another benefit of T2T to achieve remission by using less NSAIDs, lower GC, earlier use of SFZ, HCQ and TNF-i = shorter Time to Pregnancy from conception in #RA women (median 84 days) vs without pre-counselling & T2T (196 days) @RheumNow https://t.co/2ZpDLmPVt0
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Data form TARA trial Taper in RA remission
Flare free survival at 2 yrs 35%
Risk of flare is similar in ACPA+ & ACPA- RA
Risk of flare is similar if taper TNFi first or csDMARD first
@RheumNow #EULAR2024 POS0405 https://t.co/89gAglHUcw
Aurelie Najm AurelieRheumo ( View Tweet)
POS0509 looks at time to diagnosis and #comorbidity burden in #axSpa
Retrospective study in French THIN database
Diagnostic delay remains common
Increased number of MSK & non-MSK manifestations & #comorbidities over time vs 1st presentation of back pain
@RheumNow #EULAR2024
Mrinalini Dey DrMiniDey ( View Tweet)
´The health care professionals ànd caregivers also need to be well in order to deliver care for patients’ Andrea Marques speaking at the self-management session at #EULAR2024 @RheumNow https://t.co/BrEHPTbbti
Dr. Antoni Chan synovialjoints ( View Tweet)
Autoantibody measures in 5 scandinavian cohorts 6900+ RA pts
Four cit-peptides w/ high frequency
Cit Fibb36-52 (51%) Cit Fibb60-74-Cit3 (59%) Cit Fil307-324 (54%) Cit Vim60-75-Cit1 (63%)
Capture 97% of IgG CCP2+ & 22% IgG CCP2-
42% of all pts + IgG anti-Carb or Acet peptides… https://t.co/yYr6AzgipM https://t.co/6dP6Sgi3yB
Links:
Aurelie Najm AurelieRheumo ( View Tweet)
#EULAR2024
@AilsaBosworth1 highlights the programmes available for pts diagnosed with #RA via the @NRAS_UK platform
SMILE-RA and RightStart are great resources for self-management, can highly recommend to all clinicians!
@RheumNow https://t.co/SgAMKkcycE
Links:
Mrinalini Dey DrMiniDey ( View Tweet)
Just some of the barriers to supporting patients in self-management.
Important to note the array of factors at play, some easier to address than others but all should be acknowledged to tailor individual self-management guidance.
@RheumNow @ElenaNikiUK #EULAR2024 https://t.co/GJM35l275V
Mrinalini Dey DrMiniDey ( View Tweet)
« Glucocorticoids are such old drugs and we still use them so much » says Josef Smolen
Summary slide from « 75th anniversary of GCd, what have we learnt? »
@RheumNow #EULAR2024 https://t.co/XSRt44zupw
Aurelie Najm AurelieRheumo ( View Tweet)
From the Be-GIANT cohort, 44.3% of patients met the definition of early axSpA (<2 year symptom). The early axSpA group had younger age and lower frequency of radiographic sacroiliitis. Baseline characteristics and disease activity scores at baseline were similar. Physicians… https://t.co/6stDw8sHiI https://t.co/fjINAc4mw3
Links:
Dr. Antoni Chan synovialjoints ( View Tweet)
#EULAR2024
@ElenaNikiUK highlights the need to treat the patient not the disease, being cognisant of interacting factors incl #comorbidities
(Don’t think I’ll ever quite get used to seeing my work being referenced on the big screen!)
@RheumNow https://t.co/0tFUR03q8c
Mrinalini Dey DrMiniDey ( View Tweet)
THE ASSOCIATION BETWEEN DEPRESSION AND BIOLOGIC PRESCRIBING IN AXIAL SPONDYLOARTHRITIS (axSpA): LESSONS FROM AN IRISH axSpA COHORT more likely to have peripheral arthritis enthesitis psoriasis - shoukd we be formally assessing eg Beck’s DI @RheumNow #EULAR2024
Peter Nash drpnash ( View Tweet)
FINDINGS ON MRI OF THE SACROILIAC JOINTS 7 YEARS AFTER PREGNANCY IN WOMEN WITH AND WITHOUT POSTPARTUM BUTTOCK/PELVIC PAIN - source of misdiagnosis but not a cause of progressive lesions @RheumNow #EULAR2024 https://t.co/aEvlkMZtQw
Peter Nash drpnash ( View Tweet)
OP0238-HPR: effectiveness of digital patient education programme for RA self-management
Intervention led to improved self-efficacy, w minor improved RA knowledge, #HealthLiteracy & #QoL
➡️such interventions may improve self-management & lower health costs
@RheumNow #EULAR2024
Mrinalini Dey DrMiniDey ( View Tweet)
Some of the great questions in ICI-induced irAE pathophysiology, from the great Andy Cope @KingsCollegeLon
#EULAR2024 @RheumNow https://t.co/aHDqnvhboo
David Liew drdavidliew ( View Tweet)
🙏🏻I am so grateful for @RheumNow's coverage of our research about radiomics in AxSpA
⭐️I believe radiomics has potential and hope it will become a thing in Rheumatology
👇🏻Here is my interview with @bella_mehta about POS 0236 which I presented at #EULAR2024
https://t.co/yvD9yCIzQ8
Vincenzo Venerito vincevenerito ( View Tweet)
DEFINING OVERALL AND SEX-SPECIFIC BASDAI CUT-OFFS FOR DISEASE ACTIVITY STATES IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION - more data to stratify for gender at baseline all future AxSpA trials @RheumNow #EULAR2024 https://t.co/nQwCDOxN8R
Peter Nash drpnash ( View Tweet)
#EULAR2024 #scleroderma #recommend’ns @eular_org
#lung #ILD
Divide in to
#prevention vs #Rx
#Immune #suppressive #Rx vs
#antifibrotic
My thoughts -?other Rx as ⬆️MR
Likely all effective early #Rx of skin
Improve Risk of
#progression▶️ILD
@EUSTAR_org @RheumNow https://t.co/4wJyeSEHv3
Links:
Janet Pope Janetbirdope ( View Tweet)